Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
Should I Buy Sumitomo Smfg Stock In 2026 Price At 21.17 Down 0.47 20260410 Tmusz Stock Analysis T Mobile Us March 2070 5.5 Senior Notes Dip 0.16 To 21.21 20260401 How Do Market Conditions Affect Brook Infra Bipj Stock Price At 23.54 Up 0.21 20260413 What S The Outlook For Macerich Mac Stock This Year Price At 21.13 Up 2.18 20260409 What Are Bullish Arguments For Kenon Holdings Ken Stock Ken Q2 2025 Earnings Kenon Holdings Ltd. Ordinary Shares Posts 0.1 Eps 20260408 1 What Bloom Energy BE capital allocation tells us Bloom Energy Posts 229 EPS Beat MIR Mirion Technologies Inc Q4 2025 EPS falls short of estimates shares gain 234 percent on favorable investor sentiment Mount MLCI Stock Fill or Kill Smart Money Active 20260418 AEye Inc LIDRW Stock Undervalued Signal Mini Selloff 20260418 CVS Health Corporation CVS Strong Q1 2026 Performance Signals Turnaround Momentum What the market is pricing into C3ai AI ahead of earnings C3ai Misses EPS Estimates by 345 State Street Materials Select Sector SPDR ETF XLB Investment Merit Assessment for 2026 and Beyond Biogen Inc BIIB FICO Fair Isaac posts Q1 2026 doubledigit revenue growth and narrow EPS beat shares dip modestly today LNAI Lunai Bioworks reports Q1 2026 EPS of negative 008 shares slip 081 percent with no analyst earnings estimates First Trust Natural Gas ETF FCG Investment Case Analysis and Sector Peer Comparison Fonterra Cooperative Group FCG HighYield Asian Dividend Play Balancing Attractive Income Against Sustainability Risks What implementation shortfall Capricor CAPR Dips 20260429 Gen Digital Inc GEN Undervaluation Signal Amid AI Security Product Launches and Strong Q3 FY2026 Guidance ITHAX ITHA Steady at 998 Awaiting Next Catalyst 20260515 Geopolitical Tensions Rise as Trump Warns Iran Clock Is Ticking Market Implications Taoping TAOP Q2 2011 Results Fall Short EPS 39600 Revenue NA IFC and Saham Bank Launch 250 Million Risk Participation Facility for Moroccan Businesses Taiwan Silence Lingers After TrumpXi Talks A Defining Test for USChina Relations Home Depot Profit Slips as Elevated Gas Costs Weigh on Consumer Spending Greenfire GFR Q1 2026 Earnings Revenue NA Matching Views Syndax Pharmaceuticals SNDX Drops 161 Key Support at 1921 20260515 Is Forward Industries FWDI Still a Buy After 113 Rally 20260521 Endurance Technologies IPO Opens for Subscription Key Details and Market Context GT Biopharma Edges Higher Testing Key Resistance at 045 374Water SCWO Gained 310 Can It Break 245 20260520 Spotify and Universals AI Music Deal Creates New Paywall for FanMade Covers and Remixes OpenAI Eyes Landmark IPO Potential RecordBreaking Stock Market Debut on the Horizon SpaceXs Starship V3 Test Flight Marks Milestone in Space Exploration Consumer Price Index Accelerates to 38 in April Exceeding Expectations Trump Administration Rejects Iran Peace Counteroffer Extending Middle East Geopolitical Strain A10 Networks Q1 2026 Earnings EPS Surprise Drives Positive Market Reaction AVTR Q1 2026 Earnings EPS Beats Estimates Stock Rises TGEN Q1 2026 Earnings BetterThanExpected Losses Drive Positive Stock Reaction MSDL Q1 2026 Earnings Modest EPS Beat amid Flat Revenue Profile Evergy Q1 2026 Earnings EPS Beats Estimates with 458 Surprise Flexible Solutions International FSI Pulls Back as Shares Approach Key Support Zone Quince Therapeutics QNCX Jumps 9 Testing Key Resistance at 126 Brookfield Infrastructure Corporation BIPC Navigating a Modest Pullback Amid Key Levels Virtus Dividend Interest Premium Strategy Fund NFJ Sees Modest Uptick as Yield Attracts Interest Skilled Trades See 30 Pay Increase Recruitment CEO Says College Path May Be Losing Appeal Barclays Raises Price Target on JFrog to 75 Maintains Overweight Rating Twilio Q1 2026 Earnings EPS Surges Past Estimates as Profitability Gains Overshadow Growth Debate ORGN Q4 2025 Earnings Steep Loss Misses Wide Estimates as Stock Rallies XORTX Therapeutics Q1 2024 Earnings Steep EPS Miss Highlights PreRevenue Biotech Hurdles